MYC and neuroblastoma: Nevertheless, the key effects observed after chloramphenicol treatment, i.e., the mitochondrial ISR activation leading to impaired neuroblastoma cell viability in a MYC-dependent manner, provide further evidence for the newly identified mitoribosomal synthetic lethality, highlighting the potential of repurposing ribosome-targeting antibiotics in neuroblastoma therapy.